
Bafna Pharmaceuticals Ltd. (INR)80.49-0.2 (-0.3%)
Exchange ScripsBSE532989NSEBAFNAPHISININE878I01022
Indicators | Value | Signal |
---|---|---|
5-DMA | 81 | Bearish |
10-DMA | 79.2 | Bullish |
20-DMA | 76.33 | Bullish |
50-DMA | 78.72 | Bullish |
100-DMA | 79.59 | Bullish |
200-DMA | 82.19 | Bearish |
Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Promoters | 7 | 7 | 7 | 7 | 7 |
Foreign Investors | --- | --- | --- | --- | --- |
Domestic Investors | 7 | 7 | 7 | 7 | 7 |
Public Investors | 7207 | 7288 | 7384 | 7532 | 7360 |
Government | --- | --- | --- | --- | --- |
Below figures are in Rs. Crores
Particulars | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Other Income | 3 | 4 | 313 | 11 |
Operating Profit | 15 | -127 | -38 | -47 |
Interest | 1 | 21 | 69 | 115 |
Depreciation | 33 | 35 | 40 | 42 |
Profit Before Tax | -19 | -183 | -147 | -204 |
Consolidated Net Profit | -247 | -189 | -167 | -191 |
Adjusted EPS | -9 | -8 | -7 | -10 |
Below figures are in Rs. Crores
Particulars | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Share Capital | 24 | 237 | 237 | 187 |
Total Reserves | -66 | -46 | 143 | 200 |
Minority Interest | 1 | -2 | -7 | -6 |
Total Non-Current Liabilities | 30 | 298 | 413 | 547 |
Total Liabilities | 713 | 1195 | 1384 | 1783 |
Capital Work in Progress | 2 | --- | --- | --- |
Total Assets | 713 | 1195 | 1384 | 1783 |
Below figures are in Rs. Crores
Particulars | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Cash Flow from Operating Activities | -343 | -18 | -70 | -9 |
Cash Flow from Investing Activities | 328 | 154 | 380 | -54 |
Cash Flow from Financing Activitie | 73 | -138 | -306 | 63 |
Net Cash Inflow / Outflow | 58 | -2 | 3 | -1 |
Bafna Pharmaceuticals Ltd.
80.49-0.2 (-0.3%)
Announcing Stock of the Month!